Finasteride for Chronic Central Serous Chorioretinopathy

    January 2011 in “ Retina-the Journal of Retinal and Vitreous Diseases ”
    Farzin Forooghian, Annal D. Meleth, Catherine A Cukras … Catherine B. Meyerle
    Studysummary This study suggests that finasteride may be a promising treatment for chronic central serous chorioretinopathy, but larger controlled trials are needed to confirm its efficacy.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism Annals of Pharmacotherapy · 2004
    2. A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism The Journal of Clinical Endocrinology and Metabolism · 1999

    Related research 4

    1. Finasteride for Chronic Central Serous Chorioretinopathy Retina-the Journal of Retinal and Vitreous Diseases · 2011
    2. Comparison of Clinical Trials with Finasteride and Dutasteride PubMed · 2004
    3. 5-Alpha-Reductase Inhibitors/Finasteride PubMed · 1996
    4. 5α-Reductase Inhibitors/Finasteride: A Safe and Effective Treatment for Benign Prostatic Hyperplasia The Prostate · 1996